Suchen
ATAI Life Sciences NV
ATAIZur Watchlist hinzufügen
7.180USD
0.0000.00%
Handelsschluss 07-31 16:00（ET）Kurse um 15 Minuten verzögert
2.66BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über ATAI Life Sciences NV Unternehmen
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
ATAI Life Sciences NV Informationen
BörsenkürzelATAI
Name des UnternehmensAtai Beckley NV
IPO-datumJun 18, 2021
CEORao (Srinivas G)
Anzahl der mitarbeiter54
WertpapierartOrdinary Share
GeschäftsjahresendeJun 18
AddresseProf. J.H.Bavincklaan 7
StadtAMSTELVEEN
BörseNASDAQ OMX - NASDAQ BASIC
LandNetherlands
Postleitzahl1183 AT
Telefon31207932536
Websitehttps://www.atai.com/
BörsenkürzelATAI
IPO-datumJun 18, 2021
CEORao (Srinivas G)
Führungskräfte von ATAI Life Sciences NV
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Ms. Anne Johnson
Ms. Anne Johnson
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Gerd G. Kochendoerfer
Dr. Gerd G. Kochendoerfer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kevin James Craig, M.D.
Dr. Kevin James Craig, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Scott N. Braunstein, M.D.
Dr. Scott N. Braunstein, M.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von ATAI Life Sciences NV?
Die fünf größten Anteilseigner von ATAI Life Sciences NV sind: Dr. Glenn Frank Short, Ph.D.
Wie viele Institutionen halten Anteile an ATAI Life Sciences NV (ATAI)?
Mit Stand vom 2026Q1 halten 296 Institutionen Anteile an ATAI Life Sciences NV, mit einem Gesamtmarktwert von etwa 73.07M, was 19.93% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 23428346.00 gestiegen.